145 related articles for article (PubMed ID: 11306584)
1. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer.
Lynch KW; Weiss A
J Biol Chem; 2001 Jun; 276(26):24341-7. PubMed ID: 11306584
[TBL] [Abstract][Full Text] [Related]
2. High-throughput analysis revealed mutations' diverging effects on
Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T
RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135
[TBL] [Abstract][Full Text] [Related]
3. A disease-associated polymorphism alters splicing of the human CD45 phosphatase gene by disrupting combinatorial repression by heterogeneous nuclear ribonucleoproteins (hnRNPs).
Motta-Mena LB; Smith SA; Mallory MJ; Jackson J; Wang J; Lynch KW
J Biol Chem; 2011 Jun; 286(22):20043-53. PubMed ID: 21507955
[TBL] [Abstract][Full Text] [Related]
4. HnRNP L represses exon splicing via a regulated exonic splicing silencer.
Rothrock CR; House AE; Lynch KW
EMBO J; 2005 Aug; 24(15):2792-802. PubMed ID: 16001081
[TBL] [Abstract][Full Text] [Related]
5. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.
Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M
Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760
[TBL] [Abstract][Full Text] [Related]
6. Suppression of 5' splice-sites through multiple exonic motifs by hnRNP L.
Loh TJ; Choi N; Moon H; Jang HN; Liu Y; Zhou J; Zheng X; Shen H
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):363-373. PubMed ID: 28119102
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons.
Tong A; Nguyen J; Lynch KW
J Biol Chem; 2005 Nov; 280(46):38297-304. PubMed ID: 16172127
[TBL] [Abstract][Full Text] [Related]
8. HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing.
Preussner M; Schreiner S; Hung LH; Porstner M; Jäck HM; Benes V; Rätsch G; Bindereif A
Nucleic Acids Res; 2012 Jul; 40(12):5666-78. PubMed ID: 22402488
[TBL] [Abstract][Full Text] [Related]
9. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element.
Dirksen WP; Mohamed SA; Fisher SA
J Biol Chem; 2003 Mar; 278(11):9722-32. PubMed ID: 12509424
[TBL] [Abstract][Full Text] [Related]
10. A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.
Topp JD; Jackson J; Melton AA; Lynch KW
RNA; 2008 Oct; 14(10):2038-49. PubMed ID: 18719244
[TBL] [Abstract][Full Text] [Related]
11. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial control of signal-induced exon repression by hnRNP L and PSF.
Melton AA; Jackson J; Wang J; Lynch KW
Mol Cell Biol; 2007 Oct; 27(19):6972-84. PubMed ID: 17664280
[TBL] [Abstract][Full Text] [Related]
13. Modeling splicing outcome by combining 5'ss strength and splicing regulatory elements.
Müller L; Ptok J; Nisar A; Antemann J; Grothmann R; Hillebrand F; Brillen AL; Ritchie A; Theiss S; Schaal H
Nucleic Acids Res; 2022 Aug; 50(15):8834-8851. PubMed ID: 35947702
[TBL] [Abstract][Full Text] [Related]
14. Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.
Zheng ZM; Reid ES; Baker CC
J Virol; 2000 Nov; 74(22):10612-22. PubMed ID: 11044105
[TBL] [Abstract][Full Text] [Related]
15. Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.
Nielsen KB; Sørensen S; Cartegni L; Corydon TJ; Doktor TK; Schroeder LD; Reinert LS; Elpeleg O; Krainer AR; Gregersen N; Kjems J; Andresen BS
Am J Hum Genet; 2007 Mar; 80(3):416-32. PubMed ID: 17273963
[TBL] [Abstract][Full Text] [Related]
16. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
Lemaire R; Winne A; Sarkissian M; Lafyatis R
Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
[TBL] [Abstract][Full Text] [Related]
17. Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA.
Hayakawa M; Sakashita E; Ueno E; Tominaga S; Hamamoto T; Kagawa Y; Endo H
J Biol Chem; 2002 Mar; 277(9):6974-84. PubMed ID: 11744705
[TBL] [Abstract][Full Text] [Related]
18. A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45.
Rothrock C; Cannon B; Hahm B; Lynch KW
Mol Cell; 2003 Nov; 12(5):1317-24. PubMed ID: 14636588
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing.
Heyd F; Lynch KW
Mol Cell; 2010 Oct; 40(1):126-37. PubMed ID: 20932480
[TBL] [Abstract][Full Text] [Related]
20. Context-dependent regulatory mechanism of the splicing factor hnRNP L.
Motta-Mena LB; Heyd F; Lynch KW
Mol Cell; 2010 Jan; 37(2):223-34. PubMed ID: 20122404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
